PeriFlux 5000

This product is discontinued

To maintain the highest standards of safety, security, and measurement accuracy, we strongly encourage all customers to upgrade to PeriFlux 6000 as soon as your machine reaches its 10-year lifetime.

Software vulnerabilities — lack of regular maintenance exposes software to increased risk of cyberattack. Unpatched or poorly protected software can lead to unauthorized access to patient data, which may violate privacy and safety regulations. 

Measurement performance — our probes have a lifetime of 36 months. Beyond this time, we cannot guarantee basic safety and essential performance of your Perimed equipment. 

Improved software and interface — the system models of PeriFlux 6000 feature an intuitive user interface designed to streamline measurement and analysis. With enhanced data management and visualization capabilities, PeriFlux 6000 eases the process of interpreting measurements, helping clinicians and researchers to work effectively.

Broader application — PeriFlux 6000 supports a wider range of clinical exams than its predecessor. We have, for example, added support for skin perfusion pressure (SPP) measurements with updated sensors and automated flag placement. 

Ongoing updates — as a supported product, PeriFlux 6000 benefits from software updates, technical support, and maintenance. We aim to ensure that our supported instruments remain compatible with emerging clinical needs, regulatory standards, new technologies, and ever-evolving cyber threats. PeriFlux 5000 users may experience challenges with security, maintenance, and compatibility as technologies and threats evolve.

Probes for PeriFlux 5000

If you are looking for probes for a PeriFlux 5000 instrument that is within its 10-year lifetime please visit this page.

About PeriFlux 5000

When it initially launched in the mid-nineties, PeriFlux 5000 was a groundbreaking medical device. First as a research instrument and later cleared for clinical use, PeriFlux 5000 offered laser Doppler blood perfusion and transcutaneous oxygen (TcpO2) capabilities for assessing blood flow at the microvascular level — key insights for evaluating treatments and supporting diagnosis in areas like peripheral artery disease (PAD), diabetic foot, and wound healing — as well macrovascular assessments like toe pressure and TBI, and ankle pressure and ABI.

One of the main appeals of PeriFlux 5000 was its unique modular design that enabled users to tailor the system to meet their specific clinical or research needs. We offered a range of fiber optic probes for skin applications and flexible probes for assessing more complex tissue areas. This flexibility helped make PeriFlux 5000 suitable for applications beyond PAD, extending its use into areas like reconstructive surgery and dermatology. The device offered options for heated probes to induce maximal blood flow, a useful feature for evaluating endothelial function and skin blood flow response — critical indicators in vascular health.

PeriFlux 5000 played a crucial role in advancing the use of noninvasive measurement techniques in vascular healthcare. By delivering robust data on microvascular function, our technology has helped clinicians and researchers to develop more effective and less disruptive methods for clinical evaluation and research.